Study Stopped
enrollment of participants has halted prematurely; difficulty with recruitment
Ultrasound and Endometrial Hyperplasia
Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
1 other identifier
interventional
36
1 country
1
Brief Summary
The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 20, 2005
CompletedFirst Posted
Study publicly available on registry
July 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedJanuary 19, 2015
January 1, 2015
4.4 years
July 20, 2005
January 16, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Endometrial Hyperplasia
A transvaginal ultrasound of the endometrium will be performed to obtain measures of the anteroposterior endometrial thickness (in the sagittal plane), the dimensions of the endometrial cavity (thickness, length and width), and the appearance of the endometrium in addition to uterine and ovarian measures. Endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with the metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
End of study
Secondary Outcomes (1)
Endometrial Cancer
End of study
Study Arms (1)
Ultrasound and Biopsy
EXPERIMENTALTransvaginal Ultrasound and Endometrial Biopsy
Interventions
Eligibility Criteria
You may qualify if:
- Postmenopausal obese subjects, who have diabetes or a prediabetic state, or hypertension
You may not qualify if:
- Women who have had a hysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Milton S. Hershey
Hershey, Pennsylvania, 17033, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Legro, M.D.
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Obstetrics and Gynecology and Public Health Sciences
Study Record Dates
First Submitted
July 20, 2005
First Posted
July 22, 2005
Study Start
April 1, 2005
Primary Completion
September 1, 2009
Study Completion
September 1, 2009
Last Updated
January 19, 2015
Record last verified: 2015-01